WUXI APPTEC (02359.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec23

BlackRock Reduces Stake in WuXi Biologics

09:08

Dec22

Blackstone Increases Its H Shares Stake in Wuxi Biologics to 5.10%

10:36

Dec20

WuXi AppTec's Controlling Shareholder Sells 41.34 Million Shares for 3.8 Billion Yuan in 30 Days

13:42

Dec18

WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%

09:47

WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares

09:23

Dec17

JPMorgan Increases Its Stake in WuXi Biologics by 872,123 Shares

11:20

Schedules & Filings

Schedules

Filings

Oct26

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 13.17 B, Net Income 3.842 B, EPS 1.3209

Sep26

Distribution Plan(CST)

Cash dividend 0.3846 HKD

Sep9

Distribution Plan(CST)

Cash dividend 0.3846 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More